
Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors
Publication year - 2022
Publication title -
molecular oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.332
H-Index - 88
eISSN - 1878-0261
pISSN - 1574-7891
DOI - 10.1002/1878-0261.13139
Subject(s) - biomarker , adenocarcinoma , lung cancer , medicine , oncology , immune checkpoint , cancer , immune system , cancer research , immunotherapy , immunology , biology , genetics